Niemann Capital Management’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History
Bought
Maintained
Sold
Other funds holding XPH
MG
WBG
PVH
HF
Niemann Capital Management's XPH Position: Q3 2015 in Review
Niemann Capital Management sold out of State Street SPDR S&P Pharmaceuticals ETF (XPH) in Q3 2015, closing a stake of 124,316 shares — an estimated $7.75M sold.
Niemann Capital Management first reported a position in XPH in Q1 2014 and held it in 6 quarters. The position peaked at $11.2M in Q1 2015. 77 funds tracked by Wall St. Rank hold XPH as of Q3 2015.
- Niemann Capital Management reported no remaining State Street SPDR S&P Pharmaceuticals ETF position as of Q3 2015 after selling out during the quarter.
- Niemann Capital Management sold 124,316 State Street SPDR S&P Pharmaceuticals ETF shares in Q3 2015, an estimated $7.75M.
- Niemann Capital Management first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2014 and held it in 6 quarters.
- Niemann Capital Management's State Street SPDR S&P Pharmaceuticals ETF position peaked at $11.2M in Q1 2015.
- 77 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q3 2015.
Based on Niemann Capital Management's 13F filing for Q3 2015, filed 9 Nov 2015.